Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 11070
Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM30707(3-(2-DIMETHYLAMINOETHYL)-5-METHOXYINDOLE | CHEMBL7...)
Affinity DataEC50: <1.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50: <1.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582546(WO2023019367, Compound I-1)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582547(WO2023019367, Compound I-21)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582548(WO2023019367, Compound I-46)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582549(WO2023019367, Compound I-55)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582550(WO2023019367, Compound I-81)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582551(WO2023019367, Compound I-84)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582552(WO2023019367, Compound I-87)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

WIPO
LigandPNGBDBM582554(WO2023019367, Compound I-88)
Affinity DataEC50: >3.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327